$FATE
Fate Therapeutics Inc

2019 Q2 Form 10-Q Financial Statement

#000156459019029333 Filed on August 06, 2019

View on sec.gov

Income Statement

Concept 2019 Q2 2018 Q4 2018 Q2
Revenue $2.817M $1.661M $1.027M
YoY Change 174.29% 61.73% 0.1%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $5.270M $4.310M $3.820M
YoY Change 37.96% 27.51% 43.07%
% of Gross Profit
Research & Development $21.63M $14.10M $16.82M
YoY Change 28.63% 42.57% 112.14%
% of Gross Profit
Depreciation & Amortization $540.0K $320.0K $280.0K
YoY Change 92.86% 10.34% 21.74%
% of Gross Profit
Operating Expenses $26.90M $18.40M $20.63M
YoY Change 30.38% 38.66% 94.71%
Operating Profit -$24.08M -$19.61M
YoY Change 22.85% 104.86%
Interest Expense $409.0K $710.0K $425.0K
YoY Change -3.76% -384.0% -631.25%
% of Operating Profit
Other Income/Expense, Net $606.0K -$49.00K
YoY Change -1336.73%
Pretax Income -$23.48M -$16.03M -$19.65M
YoY Change 19.49% 28.24% 103.63%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$23.48M -$16.03M -$19.65M
YoY Change 19.46% 28.25% 103.77%
Net Earnings / Revenue -833.44% -964.9% -1913.73%
Basic Earnings Per Share
Diluted Earnings Per Share -$360.1K -$247.8K -$369.8K
COMMON SHARES
Basic Shares Outstanding 65.19M
Diluted Shares Outstanding

Balance Sheet

Concept 2019 Q2 2018 Q4 2018 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $162.0M $201.0M $78.00M
YoY Change 107.69% 99.21% 9.86%
Cash & Equivalents $71.44M $190.5M $36.16M
Short-Term Investments $90.60M $10.50M $41.90M
Other Short-Term Assets $3.200M $3.700M $2.000M
YoY Change 60.0% 131.25% 150.0%
Inventory
Prepaid Expenses
Receivables $0.00 $500.0K
Other Receivables $0.00 $0.00
Total Short-Term Assets $165.2M $205.2M $80.03M
YoY Change 106.38% 100.0% 11.31%
LONG-TERM ASSETS
Property, Plant & Equipment $9.225M $5.125M $2.894M
YoY Change 218.76% 100.98% 52.32%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $200.0K $526.0K $200.0K
YoY Change 0.0% 2091.67% 100.0%
Total Long-Term Assets $34.70M $7.836M $3.121M
YoY Change 1011.79% 190.65% 48.62%
TOTAL ASSETS
Total Short-Term Assets $165.2M $205.2M $80.03M
Total Long-Term Assets $34.70M $7.836M $3.121M
Total Assets $199.9M $213.0M $83.16M
YoY Change 140.37% 102.32% 12.37%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $5.410M $4.205M $3.510M
YoY Change 54.13% 150.6% 192.5%
Accrued Expenses $9.834M $10.93M $8.376M
YoY Change 17.41% 50.62% 74.5%
Deferred Revenue $5.049M $7.588M $1.776M
YoY Change 184.29% 260.48%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $5.447M $2.438M $2.011M
YoY Change 170.86%
Total Short-Term Liabilities $29.42M $27.26M $16.27M
YoY Change 80.78% 146.75% 100.9%
LONG-TERM LIABILITIES
Long-Term Debt $9.469M $12.45M $12.84M
YoY Change -26.23% -15.95% 91.57%
Other Long-Term Liabilities $33.50M $12.90M $2.200M
YoY Change 1422.73% 486.36% -45.0%
Total Long-Term Liabilities $9.469M $12.45M $12.84M
YoY Change -26.23% -15.95% 19.95%
TOTAL LIABILITIES
Total Short-Term Liabilities $29.42M $27.26M $16.27M
Total Long-Term Liabilities $9.469M $12.45M $12.84M
Total Liabilities $38.89M $39.71M $29.11M
YoY Change 33.6% 53.57% 55.66%
SHAREHOLDERS EQUITY
Retained Earnings -$328.6M -$285.4M -$252.6M
YoY Change 30.11% 30.44%
Common Stock $65.00K $65.00K $53.00K
YoY Change 22.64% 22.64%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $127.5M $160.5M $51.83M
YoY Change
Total Liabilities & Shareholders Equity $199.9M $213.0M $83.16M
YoY Change 140.37% 102.32% 12.37%

Cashflow Statement

Concept 2019 Q2 2018 Q4 2018 Q2
OPERATING ACTIVITIES
Net Income -$23.48M -$16.03M -$19.65M
YoY Change 19.46% 28.25% 103.77%
Depreciation, Depletion And Amortization $540.0K $320.0K $280.0K
YoY Change 92.86% 10.34% 21.74%
Cash From Operating Activities -$20.31M -$11.02M -$11.52M
YoY Change 76.3% 1.94% 29.88%
INVESTING ACTIVITIES
Capital Expenditures -$1.790M -$1.110M -$280.0K
YoY Change 539.29% 38.75% -31.71%
Acquisitions
YoY Change
Other Investing Activities -$90.18M $17.50M $14.00M
YoY Change -744.14% 25.0% 700.0%
Cash From Investing Activities -$91.97M $16.39M $13.72M
YoY Change -770.34% 24.17% 923.88%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 690.0K 1.900M 1.150M
YoY Change -40.0% -95.61% -157.21%
NET CHANGE
Cash From Operating Activities -20.31M -11.02M -11.52M
Cash From Investing Activities -91.97M 16.39M 13.72M
Cash From Financing Activities 690.0K 1.900M 1.150M
Net Change In Cash -111.6M 7.270M 3.350M
YoY Change -3431.04% -84.1% -135.12%
FREE CASH FLOW
Cash From Operating Activities -$20.31M -$11.02M -$11.52M
Capital Expenditures -$1.790M -$1.110M -$280.0K
Free Cash Flow -$18.52M -$9.910M -$11.24M
YoY Change 64.77% -1.0% 32.86%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
us-gaap:LicenseMember
us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
us-gaap:LicenseMember
CY2019Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
71435000
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 200
dei Local Phone Number
LocalPhoneNumber
875-1800
dei Entity Address City Or Town
EntityAddressCityOrTown
San Diego
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
651311552
dei Entity Address Address Line1
EntityAddressAddressLine1
3535 General Atomics Court
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
92121
dei City Area Code
CityAreaCode
858
dei Entity File Number
EntityFileNumber
001-36076
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7420000
CY2018Q2 us-gaap Operating Expenses
OperatingExpenses
20632000
us-gaap Operating Expenses
OperatingExpenses
49979000
CY2019Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-24084000
CY2018Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-19656000
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-43143000
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-33801000
CY2018Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.37
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.66
CY2019Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
65213364
CY2019Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.36
CY2018Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
53130518
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
95000
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-12000
CY2019Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-23385000
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.64
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
65067801
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1292000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-130000
us-gaap Net Income Loss
NetIncomeLoss
-43238000
us-gaap Net Income Loss
NetIncomeLoss
-33789000
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
52947926
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
212000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-4795000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-1053000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-500000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-519000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
336000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-893000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
2743000
fate Increase Decrease In Right Of Use Assets And Lease Liabilities Net
IncreaseDecreaseInRightOfUseAssetsAndLeaseLiabilitiesNet
709000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-24074000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
462000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
160469000
CY2019Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
199877000
CY2018Q4 fate Cirm Award Liability Current
CIRMAwardLiabilityCurrent
2106000
CY2019Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
5049000
CY2018Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
7588000
CY2019Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1572000
CY2019Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
5447000
CY2018Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
2438000
CY2019Q2 us-gaap Liabilities Current
LiabilitiesCurrent
29418000
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
27263000
CY2018Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
3401000
CY2019Q2 us-gaap Accounts Payable And Accrued Liabilities Noncurrent
AccountsPayableAndAccruedLiabilitiesNoncurrent
718000
CY2018Q4 us-gaap Accounts Payable And Accrued Liabilities Noncurrent
AccountsPayableAndAccruedLiabilitiesNoncurrent
549000
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
190514000
CY2018Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
500000
CY2019Q2 fate Short Term Investments And Related Maturity Receivables
ShortTermInvestmentsAndRelatedMaturityReceivables
90573000
CY2018Q4 fate Short Term Investments And Related Maturity Receivables
ShortTermInvestmentsAndRelatedMaturityReceivables
10493000
CY2019Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3170000
CY2018Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3689000
CY2019Q2 us-gaap Assets Current
AssetsCurrent
165178000
CY2018Q4 us-gaap Assets Current
AssetsCurrent
205196000
CY2019Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
9225000
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5125000
CY2019Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
23560000
CY2019Q2 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
227000
CY2018Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
227000
CY2019Q2 us-gaap Contract With Customer Asset Net Noncurrent
ContractWithCustomerAssetNetNoncurrent
1687000
CY2018Q4 us-gaap Contract With Customer Asset Net Noncurrent
ContractWithCustomerAssetNetNoncurrent
1958000
CY2018Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
526000
CY2019Q2 us-gaap Assets
Assets
199877000
CY2018Q4 us-gaap Assets
Assets
213032000
CY2019Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
5410000
CY2018Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
4205000
CY2019Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
9834000
CY2018Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
10926000
CY2019Q2 fate Cirm Award Liability Current
CIRMAwardLiabilityCurrent
2106000
CY2019Q2 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
5244000
CY2018Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
7500000
CY2019Q2 fate Cirm Award Liability Noncurrent
CIRMAwardLiabilityNoncurrent
1404000
CY2018Q4 fate Cirm Award Liability Noncurrent
CIRMAwardLiabilityNoncurrent
1404000
CY2019Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
26098000
CY2019Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
9469000
CY2018Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
12446000
CY2019Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2018Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q2 us-gaap Preferred Stock Value
PreferredStockValue
3000
CY2018Q4 us-gaap Preferred Stock Value
PreferredStockValue
3000
CY2019Q2 us-gaap Common Stock Value
CommonStockValue
65000
CY2018Q4 us-gaap Common Stock Value
CommonStockValue
65000
CY2019Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
455999000
CY2018Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
445799000
CY2019Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
93000
CY2018Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2000
CY2019Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-328634000
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-285396000
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
127526000
us-gaap Operating Income Loss
OperatingIncomeLoss
-44530000
us-gaap Operating Income Loss
OperatingIncomeLoss
-33659000
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
213032000
CY2019Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
1015000
CY2019Q2 us-gaap Interest Expense
InterestExpense
409000
CY2018Q2 us-gaap Interest Expense
InterestExpense
425000
us-gaap Interest Expense
InterestExpense
814000
us-gaap Interest Expense
InterestExpense
837000
CY2019Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
606000
CY2018Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
376000
CY2019Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2018Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
us-gaap Investment Income Interest
InvestmentIncomeInterest
2106000
us-gaap Investment Income Interest
InvestmentIncomeInterest
707000
CY2019Q2 us-gaap Operating Expenses
OperatingExpenses
26901000
us-gaap Operating Expenses
OperatingExpenses
35712000
CY2018Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-19605000
CY2019Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2018Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2019Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2018Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2019Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2018Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2019Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
65309891
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
64693681
CY2019Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
65309891
CY2018Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
64693681
CY2019Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2817000
CY2018Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1027000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
5449000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2053000
CY2019Q2 us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
us-gaap:LicenseMember
CY2018Q2 us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
us-gaap:LicenseMember
CY2019Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
21631000
CY2018Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
16816000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
39359000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
28292000
CY2019Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5270000
CY2018Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3816000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10620000
CY2018Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-49000
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-23478000
CY2018Q2 us-gaap Net Income Loss
NetIncomeLoss
-19654000
CY2019Q2 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
93000
CY2018Q2 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-2000
us-gaap Profit Loss
ProfitLoss
-43238000
us-gaap Profit Loss
ProfitLoss
-33789000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
983000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
567000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
8254000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2867000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
32000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
38000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
303000
us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
271000
us-gaap Paid In Kind Interest
PaidInKindInterest
159000
us-gaap Paid In Kind Interest
PaidInKindInterest
185000
us-gaap Straight Line Rent
StraightLineRent
-71000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1946000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
781000
CY2018Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
36389000
fate Common Stock Issued For License Agreements
CommonStockIssuedForLicenseAgreements
4845000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-37802000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3541000
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
106182000
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
55660000
us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
26500000
us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
26000000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-83223000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-30122000
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
270000
fate Proceeds From Cirm Award
ProceedsFromCIRMAward
1000000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1946000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1511000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-119079000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-52685000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
190741000
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
89074000
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
71662000
us-gaap Interest Paid Net
InterestPaidNet
626000
us-gaap Interest Paid Net
InterestPaidNet
613000
fate Purchases Of Property And Equipment In Accounts Payable
PurchasesOfPropertyAndEquipmentInAccountsPayable
1053000
fate Purchases Of Property And Equipment In Accounts Payable
PurchasesOfPropertyAndEquipmentInAccountsPayable
473000
us-gaap Use Of Estimates
UseOfEstimates
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Use of Estimates</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company&#8217;s unaudited condensed consolidated financial statements are prepared in accordance with United States generally accepted accounting principles (GAAP). The preparation of the Company&#8217;s unaudited condensed consolidated financial statements requires management to make estimates and assumptions that impact the reported amounts of assets, liabilities, revenues and expenses and the disclosure of contingent assets and liabilities in the Company&#8217;s unaudited condensed consolidated financial statements and accompanying notes. The most significant estimates in the Company&#8217;s unaudited condensed consolidated financial statements relate to accrued expenses. Although these estimates are based on the Company&#8217;s knowledge of current events and actions it may undertake in the future, actual results may ultimately materially differ from these estimates and assumptions.</p>
CY2019Q2 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
227000
CY2019Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
24100000
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
24100000
CY2019Q2 fate Common Stock Issuable Upon Exercise Of Outstanding Options And Restricted Stock
CommonStockIssuableUponExerciseOfOutstandingOptionsAndRestrictedStock
9900000
fate Common Stock Issuable Upon Exercise Of Outstanding Options And Restricted Stock
CommonStockIssuableUponExerciseOfOutstandingOptionsAndRestrictedStock
9900000
CY2018Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
21600000
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
21600000
CY2018Q2 fate Common Stock Issuable Upon Exercise Of Outstanding Options And Restricted Stock
CommonStockIssuableUponExerciseOfOutstandingOptionsAndRestrictedStock
7400000
fate Common Stock Issuable Upon Exercise Of Outstanding Options And Restricted Stock
CommonStockIssuableUponExerciseOfOutstandingOptionsAndRestrictedStock
7400000
fate Period To Treat Award As Grant If Award Not Treated As Loan
PeriodToTreatAwardAsGrantIfAwardNotTreatedAsLoan
P10Y
CY2019Q2 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
90480000
CY2018Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
10495000
CY2018Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
2000
CY2019Q2 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
93000
CY2019Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
90573000
CY2018Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
10493000
CY2019Q2 us-gaap Other Than Temporary Impairment Loss Debt Securities Available For Sale
OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale
0
us-gaap Other Than Temporary Impairment Loss Debt Securities Available For Sale
OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale
0
CY2019Q2 us-gaap Debt Securities Available For Sale Realized Gain Loss
DebtSecuritiesAvailableForSaleRealizedGainLoss
0
us-gaap Debt Securities Available For Sale Realized Gain Loss
DebtSecuritiesAvailableForSaleRealizedGainLoss
0
CY2019Q2 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0
CY2019Q2 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0
CY2019Q2 us-gaap Fair Value Liabilities Level1 To Level2 Transfers Amount
FairValueLiabilitiesLevel1ToLevel2TransfersAmount
0
CY2019Q2 us-gaap Fair Value Liabilities Level2 To Level1 Transfers Amount
FairValueLiabilitiesLevel2ToLevel1TransfersAmount
0
CY2019Q2 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
2036000
CY2018Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
2938000
CY2019Q2 fate Accrued Clinical Trial Related Costs Current
AccruedClinicalTrialRelatedCostsCurrent
4858000
CY2018Q4 fate Accrued Clinical Trial Related Costs Current
AccruedClinicalTrialRelatedCostsCurrent
4729000
CY2019Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
2940000
CY2018Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
3259000
CY2019Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
15000000
CY2018Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
15000000
CY2019Q2 fate Debt Instrument Discount Non Current
DebtInstrumentDiscountNonCurrent
31000
CY2018Q4 fate Debt Instrument Discount Non Current
DebtInstrumentDiscountNonCurrent
54000
CY2019Q2 fate Long Term Debt Net Of Long Term Portion Of Debt Issuance Costs And Discounts
LongTermDebtNetOfLongTermPortionOfDebtIssuanceCostsAndDiscounts
14969000
CY2018Q4 fate Long Term Debt Net Of Long Term Portion Of Debt Issuance Costs And Discounts
LongTermDebtNetOfLongTermPortionOfDebtIssuanceCostsAndDiscounts
14946000
CY2019Q2 fate Long Term Debt Gross Current
LongTermDebtGrossCurrent
5500000
CY2018Q4 fate Long Term Debt Gross Current
LongTermDebtGrossCurrent
2500000
CY2019Q2 fate Debt Instrument Discount Current
DebtInstrumentDiscountCurrent
53000
CY2018Q4 fate Debt Instrument Discount Current
DebtInstrumentDiscountCurrent
62000
CY2018Q2 fate Lease Expiration Period
LeaseExpirationPeriod
2028
us-gaap Lessee Operating Lease Existence Of Option To Extend
LesseeOperatingLeaseExistenceOfOptionToExtend
true
us-gaap Lessee Operating Lease Option To Extend
LesseeOperatingLeaseOptionToExtend
The Company can extend the term of each lease for five years after the end of 2028 at the then prevalent market rate, subject to the Company's delivery to the landlord of twelve months' prior written notice.
CY2018Q2 us-gaap Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
P5Y
us-gaap Lessee Operating Lease Existence Of Option To Terminate
LesseeOperatingLeaseExistenceOfOptionToTerminate
true
fate Early Termination Payment Description
EarlyTerminationPaymentDescription
the Company maintains the right to terminate each lease after October 2025, subject to the Company's delivery to the landlord of twelve month's prior written notice and an early termination payment of $2.5 million.
CY2018Q2 fate Lease Early Termination Option Period
LeaseEarlyTerminationOptionPeriod
2025-10
CY2018Q2 fate Payment For Early Termination Of Lease
PaymentForEarlyTerminationOfLease
2500000
CY2018Q2 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
200000
fate Increase Decrease In Operating Lease Right Of Use Asset
IncreaseDecreaseInOperatingLeaseRightOfUseAsset
7700000
fate Increase Decrease In Operating Lease Liabilites
IncreaseDecreaseInOperatingLeaseLiabilites
9600000
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
40027000
CY2019Q2 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P9Y6M
CY2019Q2 us-gaap Lessee Operating Lease Discount Rate
LesseeOperatingLeaseDiscountRate
0.080
CY2019Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
1500000
us-gaap Operating Lease Expense
OperatingLeaseExpense
3000000
CY2019Q2 fate Straightline Recognition Of Fixed Payments
StraightlineRecognitionOfFixedPayments
900000
fate Straightline Recognition Of Fixed Payments
StraightlineRecognitionOfFixedPayments
1900000
CY2019Q2 us-gaap Variable Lease Cost
VariableLeaseCost
600000
us-gaap Variable Lease Cost
VariableLeaseCost
1100000
CY2019Q2 us-gaap Short Term Lease Cost
ShortTermLeaseCost
200000
us-gaap Short Term Lease Cost
ShortTermLeaseCost
200000
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
1825000
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
3760000
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
3873000
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
3989000
CY2019Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
4109000
CY2019Q2 fate Lessee Operating Lease Liability Payments Due Year Six
LesseeOperatingLeaseLiabilityPaymentsDueYearSix
4232000
CY2019Q2 fate Lessee Operating Lease Liability Payments Due After Year Six
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearSix
18239000
CY2019Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
12357000
CY2019Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
27670000
CY2019Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4386000
CY2018Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1485000
CY2019Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1258000
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3868000
CY2019Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
2000
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
-19760000
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
145837000
CY2019Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
688000
CY2019Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4386000
CY2019Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
93000
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
77189000
CY2018Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
606000
CY2018Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1382000
CY2018Q1 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
37000
CY2018Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-10000
CY2018Q1 us-gaap Net Income Loss
NetIncomeLoss
-14135000
CY2018Q1 us-gaap Stockholders Equity
StockholdersEquity
64995000
CY2018Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
175000
CY2018Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1485000
CY2018Q2 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
19000
CY2018Q2 fate Stock Issued During Period Value For Licence Agreements
StockIssuedDuringPeriodValueForLicenceAgreements
4845000
CY2018Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-2000
CY2018Q2 us-gaap Stockholders Equity
StockholdersEquity
51825000

Files In Submission

Name View Source Status
0001564590-19-029333-index-headers.html Edgar Link pending
0001564590-19-029333-index.html Edgar Link pending
0001564590-19-029333.txt Edgar Link pending
0001564590-19-029333-xbrl.zip Edgar Link pending
fate-10q_20190630.htm Edgar Link pending
fate-20190630.xml Edgar Link completed
fate-20190630.xsd Edgar Link pending
fate-20190630_cal.xml Edgar Link unprocessable
fate-20190630_def.xml Edgar Link unprocessable
fate-20190630_lab.xml Edgar Link unprocessable
fate-20190630_pre.xml Edgar Link unprocessable
fate-ex311_7.htm Edgar Link pending
fate-ex321_6.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending